GlassScriptPhysician profile
Thomas A Lebeau
NPI 1659587897
$13,840.94
in general payments reported to CMS, 2019-2025
48 companies · $2,828 in 2025
The $2,828 reported for 2025 was more than what 88% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $942 · 2020: $456 · 2021: $1,035 · 2022: $704 · 2023: $5,241 · 2024: $2,636 · 2025: $2,828.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $7,933 · Food and Beverage: $2,771.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $7,933.33 |
| Food and Beverage | $2,770.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $8,002.81 | 2022-2025 | Venacure 1470 Pro |
| Horizon Therapeutics Plc | $874.41 | 2019-2023 | Krystexxa |
| Medtronic, INC. | $440.98 | 2021-2025 | Closurefast, Venaseal |
| Organogenesis INC. | $439.89 | 2020-2024 | Apligraf, Nushield, Affinity |
| Kerecis Limited | $388.19 | 2019-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Ucb, INC. | $272.79 | 2023-2024 | Cimzia |
| Abbott Laboratories | $248.29 | 2023-2024 | Esprit, Diamondback Peripheral |
| Averitas Pharma INC. | $235.73 | 2023-2025 | Qutenza |
| Medtronic Vascular, INC. | $194.99 | 2019-2020 | |
| Abbvie INC. | $186.91 | 2021-2022 | |
| Cardiovascular Systems INC. | $172.03 | 2022 | |
| Acera Surgical, INC. | $170.66 | 2022-2025 | Restrata Wound Matrix |
| Smith+Nephew, INC. | $162.27 | 2019-2025 | Collagenase Santyl, Regranex |
| Paragon 28, INC. | $147.73 | 2024 | Hammertube Sterile Implant Kits |
| Amgen INC. | $134.48 | 2023-2025 | Otezla, Enbrel, Krystexxa |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $120.82 | 2024 | Penumbra System |
| Astrazeneca Pharmaceuticals LP | $116.80 | 2023-2024 | Saphnelo |
| Next Science LLC | $115.98 | 2023-2024 | Blastx, Xperience, Surgx |
| Stimwave Technologies Incorporated | $113.06 | 2019-2020 | |
| Kci USA, INC. | $108.43 | 2019 | |
| Bioventus LLC | $101.78 | 2022-2024 | Durolane, Exogen Ultrasound Bone Healing System |
| Mallinckrodt Hospital Products INC. | $95.15 | 2023-2024 | Acthar |
| Ortho Solutions INC | $93.80 | 2019 | |
| Access Pro Medical, LLC | $91.29 | 2023 | Matriderm |
| Melinta Therapeutics, LLC | $79.13 | 2019-2023 | Kimyrsa |
| Sanara Medtech INC. | $70.32 | 2021 | |
| Biowound Solutions, INC. | $65.24 | 2025 | Bio-Connekt |
| Grt US Holding, INC. | $60.10 | 2020-2022 | |
| Convatec INC. | $52.64 | 2023-2024 | |
| Misonix INC | $41.36 | 2019-2020 | |
| Paratek Pharmaceuticals, INC. | $41.12 | 2022 | |
| Allergan, INC. | $35.97 | 2019 | |
| Nabriva Therapeutics, Plc | $35.81 | 2022 | |
| Janssen Biotech, INC. | $35.04 | 2023 | Simponi Aria |
| Venclose INC. | $34.57 | 2020 | |
| Mimedx Group, INC. | $28.61 | 2025 | |
| Highridge Medical LLC | $27.63 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Ebi, LLC | $27.63 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Zyla Life Sciences, INC. | $27.38 | 2020 | |
| Solventum Corporation | $25.14 | 2024 | Activ.A.C., Promogran |
| Heron Therapeutics, INC. | $21.26 | 2021 | |
| Omeza LLC | $17.65 | 2024 | |
| Acelrx Pharmaceuticals, INC. | $17.35 | 2021 | |
| Embody, INC. | $16.05 | 2021 | |
| Leo Pharma INC. | $14.19 | 2020 | |
| Orthofix Medical, INC. | $13.59 | 2023 | Physio-Stim |
| Hikma Pharmaceuticals USA | $12.55 | 2020 | |
| Celularity INC. | $11.34 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Lebeau listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.